Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.34M | -3.49M | -4.08M | -3.53M | -2.97M |
| Total Depreciation and Amortization | 0.00 | 1.00K | 1.00K | 1.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 222.00K | 11.00K | 468.00K | 150.00K | 203.00K |
| Change in Net Operating Assets | 741.00K | 342.00K | 112.00K | 196.00K | 22.00K |
| Cash from Operations | -2.38M | -3.13M | -3.50M | -3.18M | -2.75M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -156.00K | -112.00K | 0.00 | -158.00K | -101.00K |
| Issuance of Common Stock | 4.44M | 0.00 | 4.01M | 2.50M | 17.00K |
| Repurchase of Common Stock | 0.00 | 0.00 | -25.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -120.00K | -68.00K | -410.00K | -321.00K | -50.00K |
| Cash from Financing | 4.16M | -180.00K | 3.58M | 2.02M | -134.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.78M | -3.31M | 77.00K | -1.16M | -2.88M |